Antimicrobial and immunomodulatory effects of Lactobacillus Acidophilus postbiotics

Date Published April 20, 2026

Northeast Basic Sciences and Genetics
Investigating antimicrobial and immunomodulatory effects of Lactobacillus acidophilus postbiotics on host defenses and resolution.
This project investigates the antimicrobial and immunomodulatory effects of Lactobacillus acidophilus postbiotics in the context of severe bacterial infections and dysregulated host responses. The work builds on immune response to bacterial infection, the importance of resolving inflammation and the biological roles of specialized pro-resolving mediators (SPMs). Severe infections such as sepsis provoke an intense innate immune activation that must be resolved to restore homeostasis; failure to resolve inflammation can lead to a paradoxical state in which the host becomes immunocompromised and vulnerable to secondary infections. SPMs endogenously produced lipid mediators derived from arachidonic acid and omega-3 fatty acids, including lipoxins and resolvins are highlighted in the lab's overarching research interests for their infection resolution activity. Positioned within this conceptual framework, the Lactobacillus acidophilus postbiotics project aims to explore whether bacterially derived postbiotic products can exert antimicrobial activity while modulating host immune pathways that govern inflammation resolution and pathogen clearance.

The study frames postbiotics as biologically active metabolites or secreted factors from Lactobacillus acidophilus that may influence both bacterial virulence and host immune cell behavior. Given the lab's focus on mechanisms by which resolution is actively achieved reducing neutrophil activity, increasing macrophage recruitment, and augmenting monocyte/macrophage functionality the project seeks to assess how postbiotic interventions might intersect with these processes. Key goals include determining whether Lactobacillus acidophilus postbiotics have direct antimicrobial effects against relevant bacterial pathogens and whether they influence host cell processes tied to resolution, such as neutrophil clearance, macrophage recruitment and activation, and attenuation of systemic inflammatory responses. The work aims to situate postbiotic activity alongside established resolution pathways mediated by SPMs, thereby evaluating potential complementary or synergistic mechanisms.

This research is intended to address clinical needs identified in the lab's narrative: despite advances in antibiotics, more effective treatments are required for severe bacterial infections. By interrogating postbiotic effects on both microbial virulence and host defense, the project aspires to identify novel therapeutic strategies that not only suppress pathogens but also promote active resolution of inflammation and restoration of immune competence. Outcomes of interest include characterization of postbiotic antimicrobial spectra, modulation of inflammatory mediator profiles, impacts on innate immune cell recruitment and function, and potential interactions with SPM-related pathways. Findings could inform translational approaches that leverage microbiota-derived products to improve outcomes in conditions characterized by dysregulated inflammation and compromised host defense, such as sepsis.
Learn more

COM Affiliation

Funding Type

Foundation/Non-profit

Update This Listing

Help us provide the most up-to-date information about this project.

Contact Us
Questions?

For questions about these research projects please email us.

Contact Us
This summary was generated by AACOM. The researchers and authors of this work were not involved in the curation of this summary.